Acasti pharma announces patents for gtx-104 in europe, gtx-102 in the u.s. and gtx-101 in japan

Laval, quÉbec, march 22, 2022 (globe newswire) -- acasti pharma inc. (“acasti” or the “company”) (nasdaq: acst and tsx-v: acst), announces the following patent notifications and awards relating to the company's three lead drug candidates:

ACST Ratings Summary

ACST Quant Ranking